Mayo Clinic study reveals positive numbers for breast cancer screening device

Amid growing evidence that mammography alone is not sufficient in screening women with dense breast tissue for breast cancer, a new Mayo Clinic study shows that adding an innovative molecular breast imaging solution to traditional mammography could be more accurate and cost-effective.

Data registry finds younger orthopedics patients are no healthier than older ones

The Framingham Heart Study has revolutionized cardiology over the decades, leading to insights like the dangers of smoking in the 1960s, elevated blood pressure in the 1970s and more recently, genomic risk factors.  Another Massachusetts study is underway, with the intention of becoming the equivalent study in the orthopedics arena, according to Dr. David Ayers, chair of the orthopedics department at the University of Massachusetts Medical School in Worcester.

What does Google’s corporate shuffle mean for its biotech ambitions?

Google is divvying up its composite parts, becoming, depending on whom you ask, the new Berkshire Hathaway, the next General Electric or something heretofore never seen.  However, the move could have mixed implications for Google’s nascent but growing life sciences empire — including the high-profile, secretive biotech Calico–as shuffling things around could expose such moonshot projects to the pitchforks of profit-hungry investors.

Google joins forces with Dexcom for miniaturized glucose monitor

Google has been scouting out promising med tech projects since launching its life sciences division a couple of years ago, inking deals to expand its reach in patient monitoring and wearable health.  In its latest foray the company will work with Dexcom to develop cheaper, miniaturized glucose monitors, combining its electronics platform with Dexcom’s sensor technology to improve care for patients.